(S1 (S (NP (NNP Immunex) (NNP Corp.)) (VP (VBD said) (SBAR (S (NP (PRP$ its) (NNS scientists)) (VP (VBN isolated) (NP (NP (DT a) (NN molecule)) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB hold) (NP (NN potential)) (PP (IN as) (NP (NP (DT a) (NN treatment)) (PP (IN for) (NP (NP (NNS disruptions)) (PP (IN of) (NP (DT the) (NN immune-system))) (, ,) (VP (VBG ranging) (PP (PP (IN from) (NP (JJ organ-transplant) (NN rejection))) (, ,) (PP (TO to) (NP (NNS allergies) (CC and) (NN asthma)))))))))))))))))) (. .)))

(S1 (S (NP (DT The) (NN molecule)) (VP (VBZ is) (NP (NP (DT the) (NN mouse) (NN version)) (PP (IN of) (NP (NP (DT a) (NN protein)) (VP (VBD called) (NP (DT the) (NN interleukin-4) (NN receptor))))))) (. .)))

(S1 (S (NP (NN IL-4)) (VP (VBZ is) (NP (NP (DT a) (NN hormone)) (SBAR (WHNP (WDT which)) (S (VP (VBZ directs) (NP (NP (DT the) (NN growth) (CC and) (NN function)) (PP (IN of) (NP (NP (JJ white) (NN blood) (NNS cells)) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN body) (POS 's)) (JJ immune) (NN response)))))))))))) (. .)))

(S1 (S (NP (NP (DT The) (JJ IL-4) (NN receptor)) (PP (IN on) (NP (NP (DT the) (NN surface)) (PP (IN of) (NP (JJ such) (NNS cells)))))) (VP (VBZ receives) (NP (NP (NP (DT the) (NN hormone) (POS 's)) (NN message)) (SBAR (S (VP (TO to) (VP (VB rally) (NP (NP (DT the) (NN body) (POS 's)) (NN defense)))))))) (. .)))

(S1 (S (CC But) (PP (IN in) (NP (NP (JJ certain) (NNS conditions)) (PP (JJ such) (IN as) (NP (NP (JJ autoimmune) (NNS diseases)) (CC and) (NP (NNS allergies) (CC and) (NN transplant) (NN rejection)))))) (, ,) (NP (NNS doctors)) (VP (MD would) (VP (VB like) (S (VP (TO to) (VP (VB damp) (NP (DT the) (JJ immune) (NN response)) (SBAR (IN so) (S (NP (JJ such) (NNS cells)) (VP (VBP do) (RB n't) (VP (VB touch) (PRT (RP off)) (NP (NP (JJ harmful) (JJ inflammatory) (NNS reactions)) (CC or) (NP (NN cell) (NN destruction)))))))))))) (. .)))

(S1 (S (S (NP (NP (DT A) (JJ soluble) (NN form)) (PP (IN of) (NP (DT the) (NN receptor)))) (VP (MD might) (VP (VB turn) (PRT (RP off)) (NP (NP (DT a) (JJ specific) (NN part)) (PP (IN of) (NP (DT the) (JJ immune) (NN response)))) (PP (IN without) (NP (JJ general) (JJ immune) (NN suppression)))))) (, ,) (NP (DT the) (NN company)) (VP (VBD said)) (. .)))

(S1 (S (NP (DT The) (JJ IL-4) (NN receptor)) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (NP (CD five) (JJ such) (NNS receptors)) (SBAR (S (VP (TO to) (VP (VB be) (VP (VBN developed) (CC and) (VBN tested) (PP (IN by) (NP (NP (NNP Receptech) (NNP Corp.)) (, ,) (NP (NP (DT a) (NN spinoff)) (PP (IN of) (NP (NNP Immunex)))))) (, ,) (PP (IN through) (NP (DT a) (VBN proposed) (ADJP (QP ($ $) (CD 30) (CD million))) (JJ initial) (JJ public) (NN offering)))))))))))) (. .)))

(S1 (S (NP (NNP Immunex)) (VP (MD will) (VP (VB contract) (PP (IN with) (NP (DT the) (NN spinoff) (S (VP (TO to) (VP (VB provide) (NP (NP (DT the) (NN research) (, ,) (NN development) (CC and) (JJ initial) (NN testing)) (PP (IN of) (NP (DT the) (JJ new) (NNS agents))))))))))) (. .)))

(S1 (S (NP (NNP Immunex)) (VP (MD will) (VP (VB have) (NP (DT the) (NN option) (S (VP (TO to) (VP (VB buy) (PRT (RP back)) (NP (NNP Receptech) (NNS shares)) (PP (IN after) (NP (CD five) (NNS years))))))))) (. .)))

